HAYA Therapeutics

Lausanne, Switzerland · Founded 2017 · Privately Held (backing)

Operator of a precision therapeutics company intended to discover and develop tissue and cell-selective genomic medicines for fibrotic diseases. HAYA Therapeutics is based in Lausanne, Switzerland and was founded in 2017. Its last reported valuation was $115 million in Apr 2025. It has raised $101 million.

Last reported valuation

$115.5M

Oct 2026

Priced at

—

Total raised

$101.0M

Last round

—

How much has HAYA Therapeutics raised?

$101.0Macross 0 recorded rounds

Free account

More of HAYA Therapeutics with a free account

·The complete investor list: 18 names
·Watch HAYA Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

HAYA Therapeutics investors

18 investors are on record for HAYA Therapeutics, including MassChallenge, Venture Kick, Alexandria Venture Investments and Earlybird Venture Capital.

For fundraisers

Raising for a company like HAYA Therapeutics?

18 investors have backed HAYA Therapeutics.

See all 18 investors →

Frequently asked about HAYA Therapeutics

How much has HAYA Therapeutics raised?: HAYA Therapeutics has raised $101.0M in total across 0 recorded funding rounds.